We also observed a reduced expression of the GR‐induced genes DUSP1 and TSC22D3 in the blood of relapsing GC‐resistant patients with MS compared to relapsing GC‐sensitive patients with MS, as demonstrated by others.33, 34. This evidence concerns the gene TSC22D3 and myeloid sarcoma.